Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction

Journal of Experimental Medicine

Volumn 188, Issue 2, 1998, Pages 409-414

  Kurts, Christian ^a,b   Miller, Jacques F A P ^a   Subramaniam, Rathan M ^a   Carbone, Francis R ^b   Heath, William R ^a,c  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b MONASH UNIVERSITY MEDICAL SCHOOL   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Antigen presentation; Antigen presenting cells; Apoptosis; CD8+ T lymphocytes; T cell activation

Indexed keywords

CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; CELL DESTRUCTION; CYTOTOXIC T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN PRESENTATION; CD8-POSITIVE T-LYMPHOCYTES; HISTOCOMPATIBILITY ANTIGENS CLASS I; LYMPHOCYTE ACTIVATION; MICE;

EID: 0031821976     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.2.409     Document Type: Article

References (26)

1. Germain, R.N., and D.H. Margulies. 1993. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11:403-450.
2. Bevan, M.J. 1976. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143: 1283-1288.
3. Bevan, M.J. 1976. Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming. J. Immunol. 117:2233-2238.
4. Gordon, R.D., B.J. Mathieson, L.E. Samelson, E.A. Boyse, and E. Simpson. 1976. The effect of allogeneic presensitization on H-Y graft survival and in vitro cell-mediated responses to H-y antigen. J. Exp. Med. 144:810-820.
5. Gooding, L.R., and C.B. Edwards. 1980. H-2 antigen requirements in the in vitro induction of SV40-specific cytotoxic T lymphocytes. J. Immunol. 124:1258-1262.
6. von Boehmer, H., and K. Hafen. 1986. Minor but not major histocompatibility antigens of thymus epithelium tolerize precursors of cytolytic T cells. Nature. 320:626-628.
7. Carbone, F.R., and M.J. Bevan. 1990. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J. Exp. Med. 171:377-387.
8. Huang, A.Y., P. Golumbek, M. Ahmadzadeh, E. Jaffee, D. Pardoll, and H. Levitsky. 1994. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science. 264:961-965.
9. Arnold, D., S. Faath, H. Rammensee, and H. Schild. 1995. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J. Exp. Med. 182:885-889.
10. Kurts, C., W.R. Heath, F.R. Carbone, J. Allison, J.F.A.P. Miller, and H. Kosaka. 1996. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J. Exp. Med. 184:923-930.
11. + T cells. J. Exp. Med. 186:239-245.
12. + T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J. Exp. Med. 186: 2057-2062.
13. Pulaski, B.A., K.Y. Yeh, N. Shastri, K.M. Maltby, D.P. Penney, E.M. Lord, and J.G. Frelinger. 1996. Interleukin 3 enhances cytotoxic T lymphocyte development and class I major histocompatibility complex "re-presentation" of exogenous antigen by tumor-infiltrating antigen-presenting cells. Proc. Natl. Acad. Sci. USA. 93:3669-3674.
14. Bennett, S.R., F.R. Carbone, F. Karamalis, J.F.A.P. Miller, and W.R. Heath. 1997. Induction of a CD8 cytotoxic T lymphocyte response by cross-priming requires cognate CD4 help. J. Exp. Med. 186:65-70.
15. Bevan, M.J. 1987. Antigen recognition. Class discrimination in the world of immunology. Nature. 325:192-194.
16. Rock, K.L. 1996. A new foreign policy: MHC class I molecules monitor the outside world. Immunol. Today. 17:131-137.
17. Blanas, E., F.R. Carbone, J. Allison, J.F.A.P. Miller, and W.R. Heath. 1996. Induction of autoimmune diabetes by oral administration of autoantigen. Science. 274:1707-1709.
18. Lyons, A.B., and C.R. Parish. 1994. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods. 171:131-137.
19. Hodgkin, P.D., J.H. Lee, and A.B. Lyons. 1996. B cell differentiation and isotype switching is related to division cycle number. J. Exp. Med. 184:277-281.
20. Albert, M.L., B. Sauter, and N. Bhardwaj. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature. 392:88-91.
21. Ohashi, P.S., S. Oehen, K. Buerki, H. Pircher, C.T. Ohashi, B. Odermatt, B. Malissen, R.M. Zinkernagel, and H. Hengartner. 1991. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell. 65:305-317.
22. Oldstone, M.B., M. Nerenberg, P. Southern, J. Price, and H. Lewicki. 1991. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell. 65:319-331.
23. Heath, W.R., F. Karamalis, J. Donoghue, and J.F. Miller. 1995. Autoimmunity caused by ignorant CD8+ T cells is transient and depends on avidity. J. Immunol. 155:2339-2349.
24. Lo, D., J. Freedman, S. Hesse, R.D. Palmiter, R.L. Brinster, and L.A. Sherman. 1992. Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+ and CD8+ T cells. Eur. J. Immunol. 22:1013-1022.
25. Adams, T.E., S. Alpert, and D. Hanahan. 1987. Non-tolerance and autoantibodies to a transgenic self antigen expressed in pancreatic beta cells. Nature. 325:223-228.
26. Guerder, S., and P. Matzinger. 1992. A fail-safe mechanism for maintaining self-tolerance. J. Exp. Med. 176:553-564.